| 1 |
33639139 | Anti-CD19 mAb modified mesoporous titanium dioxide as exclusively targeting vector for efficient B-lymphoblastic leukemia therapy. | 2021 Jul |
7 |
| 2 |
32635973 | Anti-CD19 mAb-conjugated human serum albumin nanoparticles effectively deliver doxorubicin to B-lymphoblastic leukemia cells. | 2020 Jul 1 |
12 |
| 3 |
29928472 | Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells. | 2018 Jun 1 |
4 |
| 4 |
18068849 | Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv. | 2008 Feb 18 |
1 |
| 5 |
10825443 | Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo. | 2000 Jun 1 |
2 |
| 6 |
9699662 | In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. | 1998 Aug 1 |
1 |